# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA512210 | 7 | GI50 | = | 5.3 | uM | ALA3587305 | nM | Homo sapiens | |||
2. | ALA3586094 | beta-santalol | GI50 | = | 6.3 | uM | ALA3587305 | nM | Homo sapiens | |||
3. | ALA512210 | 7 | TGI | = | 8.2 | uM | ALA3587305 | nM | Homo sapiens | |||
4. | ALA3586094 | beta-santalol | TGI | = | 9.6 | uM | ALA3587305 | nM | Homo sapiens | |||
5. | ALA512210 | 7 | LC50 | = | 12.2 | uM | ALA3587305 | nM | Homo sapiens | |||
6. | ALA3586094 | beta-santalol | LC50 | = | 15.9 | uM | ALA3587305 | nM | Homo sapiens | |||
7. | XL888 | 12i | IC50 | = | 5.5 | nM | ALA2215514 | 8.26 | nM | Homo sapiens | ||
8. | GW2580 | K00591a, Diaminopyrimidine1 | IC50 | = | 29 | uM | ALA1959929 | 4.54 | nM | Homo sapiens | ||
9. | Pazopanib | 13 | Activity | 0 | ALA983776 | Active | Homo sapiens | |||||
10. | Pazopanib | 13 | INH | = | 110 | % | ALA983772 | % | Homo sapiens | |||
11. | Pazopanib | 13 | INH | = | 102 | % | ALA983771 | % | Homo sapiens | |||
12. | Pazopanib | 13 | INH | = | 99 | % | ALA983770 | % | Homo sapiens | |||
13. | GW843682X | 2 | IC50 | = | 678 | nM | ALA941581 | 6.17 | nM | Homo sapiens | ||
14. | ALA475600 | 36 | IC50 | = | 2.71 | uM | ALA990362 | 5.57 | nM | Homo sapiens | ||
15. | ALA473436 | 26 | IC50 | = | 0.57 | uM | ALA990362 | 6.24 | nM | Homo sapiens | ||
16. | ALA474431 | 25 | IC50 | = | 0.1 | uM | ALA990362 | 7.00 | nM | Homo sapiens | ||
17. | ALA475769 | 23 | IC50 | = | 0.14 | uM | ALA990362 | 6.85 | nM | Homo sapiens | ||
18. | ALA473428 | 20 | IC50 | = | 0.1 | uM | ALA990362 | 7.00 | nM | Homo sapiens | ||
19. | Lapatinib ditosylate monohydrate | Tykerb | IC50 | = | 120 | nM | ALA990362 | 6.92 | nM | Homo sapiens | ||
20. | ALA506414 | 33 | IC50 | = | 10.08 | uM | ALA990359 | 5.00 | nM | Homo sapiens |